Military medical research and development services
Ended Awarded Last action
- Contract number
- HT001122F0101
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,500
Award facts
- Opportunity
-
- DHA omnibus IV military medical research and development draft RFP Pre-Solicitation · HT001121R0004 · Posted Nov 13, 2020
- Contract value 100% obligated
- $2,500.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Falls Church, VA 22042, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a $2,500 delivery order to Lovelace Biomedical Research Institute under the Omnibus IV Military Medical Research and Development Indefinite Delivery/Indefinite Quantity (IDIQ) contract. This firm fixed-price award, issued on June 19, 2023, supports military medical research and development services with performance in Falls Church, Virginia. No small business set-aside was applied to this contract action.
Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization headquartered in Albuquerque, New Mexico, brings extensive federal research capabilities to this engagement. The organization specializes in preclinical research services including animal studies, analytical testing, disease model development, toxicology, and medical countermeasure development. Lovelace holds substantial federal IDIQ contracts with agencies including the National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences, and the Office of the Assistant Secretary for Preparedness and Response, demonstrating its established capacity to support complex Department of Defense medical research requirements.
Quick answers
Who was awarded contract HT001122F0101?
HT001122F0101 was awarded to Lovelace Biomedical Research Institute by Defense Health Agency (Department of Defense) on June 19, 2023.
How much is contract HT001122F0101 worth?
The government has obligated $2,500 on HT001122F0101.
Is contract HT001122F0101 an order under another contract?
Yes. HT001122F0101 is a delivery order under HT001122D0030, an indefinite delivery contract, on Omnibus IV Military Medical Research And Development (OMNIBUS IV).
Was contract HT001122F0101 competed?
The extent of competition for HT001122F0101 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award